Sort
130,381 grants matching “hiv”
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa
$1,803,317Diane V Havlir · University Of California, San Francisco · P01 · FY2017 · HD
Studies in humans to delineate the basis for viral persistence
$1,802,930David M. Margolis · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-Exposure
$1,801,942Alessandro Grattoni · Methodist Hospital Research Institute · R01 · FY2025 · AI
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico
$1,801,861Timothy J Wilkin · Weill Medical Coll Of Cornell Univ · U54 · FY2019 · CA
SELECTIVE EXCELLENCE IN HEALTH-RELATED RESEARCH
$1,801,742University Of Hawaii At Manoa · G12 · FY2000 · RR
CORE SURVEILLANCE AND HIV INCIDENCE SURVEILLANCE
$1,801,725Ling Hsu · San Francisco Department Of Public Health · U62 · FY2009 · PS
Immunology and Virology of Acute HIV Infection
$1,801,614James Ivan Mullins · University Of Washington · P01 · FY2006 · AI
Sample Collection and General Screening Protocols
$1,801,500Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Functional Genomics and HCV-Associated Liver Disease
$1,801,335Michael G Katze · University Of Washington · P30 · FY2007 · DA
Noncoding RNA structures and interactions in cellular stress responses and immunity
$1,801,318Jinwei Zhang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
GHESKIO HIV Clinical Trial Unit
$1,801,235Jean William Pape · Gheskio Center · UM1 · FY2020 · AI
T Cell Immune Responses To HIV And Other Pathogens
$1,800,765Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
NONHUMAN PRIMATE (NHP) CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH DEVELOPMENT
$1,800,685Amitinder Kaur · Tulane University Of Louisiana · N01 · FY2020 · AI
Washington Metro Women's Interagency HIV Study(WIHS)lll
$1,800,669Georgetown University · U01 · FY2003 · AI
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$1,800,256Jay A Berzofsky · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Circumcision: HIV/STIs and behaviors in a RCT and post-RCT surveillance; Rakai
$1,800,254Ronald H Gray · Johns Hopkins University · U01 · FY2011 · AI
Eliciting VRC01-like bNAbs by Specifically Designed Env Immunogens
$1,800,250Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2018 · AI
MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among YMSM
$1,800,000Rebecca Schnall · Columbia University Health Sciences · UG3 · FY2022 · AI
CLINICAL SITE MONITORING PROJECT
$1,800,000Ppd, Inc. · N01 · FY2000 · AI
Modifications to improve HIV neutralizing antibodies
$1,800,000John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Modifications to improve HIV neutralizing antibodies
$1,800,000John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
LSUHSC-NO Comprehensive Alcohol-HIV/AIDS Research Center
$1,800,000Patricia E Molina · Lsu Health Sciences Center · P60 · FY2015 · AA
GH15-1572, S. Sudan: Strengthening the Capacity to Scale-up HIV Prevention, Care and Treatment Programs in South Sudan under the President's Emergency Plan for AIDS Relief (PEPFAR) - South Sudan
$1,800,000Veronique Bortolotti · Columbia University Health Sciences · U2G · FY2015 · GH
Strengthening and Expanding rountine HIV counceling & testing & integrating preve
$1,800,000Karen Blyth · Intrahealth International, Inc. · U2G · FY2008 · PS
Modifications to improve HIV neutralizing antibodies
$1,800,000Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI